These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 24411404)

  • 21. Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.
    Brito-Zerón P; Ramos-Casals M;
    Curr Opin Rheumatol; 2014 Sep; 26(5):520-7. PubMed ID: 25050925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing health-related quality of life in primary Sjögren's syndrome-The PSS-QoL.
    Lackner A; Stradner MH; Hermann J; Unger J; Stamm T; Graninger WB; Dejaco C
    Semin Arthritis Rheum; 2018 Aug; 48(1):105-110. PubMed ID: 29395257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.
    Dumusc A; Ng WF; James K; Griffiths B; Price E; Pease C; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Gupta M; McLaren J; Cooper A; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman S
    Swiss Med Wkly; 2018; 148():w14588. PubMed ID: 29442344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?
    Lendrem D; Mitchell S; McMeekin P; Gompels L; Hackett K; Bowman S; Price E; Pease CT; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng WF;
    Rheumatology (Oxford); 2015 Apr; 54(4):655-9. PubMed ID: 25240612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation and psychometric properties of the Eular Sjögren's Syndrome Patient Reported Index (ESSPRI) into Brazilian Portuguese.
    Paganotti MA; Valim V; Serrano ÉV; Miyamoto ST; Giovelli RA; Santos MC
    Rev Bras Reumatol; 2015; 55(5):439-45. PubMed ID: 26345467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sjögren's Syndrome: Early diagnosis and effective treatment].
    Witte T
    Dtsch Med Wochenschr; 2018 Dec; 143(24):1778-1782. PubMed ID: 30508859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collaborative research into outcome measures in Sjögren's syndrome. Update on disease assessment.
    Bowman SJ
    Scand J Rheumatol Suppl; 2002; 116():23-7. PubMed ID: 12109539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contemporary diagnostics of the primary Sjögren's syndrome].
    Parada-Turska J
    Wiad Lek; 2016; 69(4):680-685. PubMed ID: 27941210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
    Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).
    Meiners PM; Vissink A; Kroese FG; Spijkervet FK; Smitt-Kamminga NS; Abdulahad WH; Bulthuis-Kuiper J; Brouwer E; Arends S; Bootsma H
    Ann Rheum Dis; 2014 Jul; 73(7):1393-6. PubMed ID: 24473674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) and Other Patient-Reported Outcomes in the Assessment of Glandular Dysfunction in Primary Sjögren's Syndrome.
    Ture HY; Kim NR; Nam EJ
    Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of sleep quality on clinical features of primary Sjögren's syndrome.
    Chung SW; Hur J; Ha YJ; Kang EH; Hyon JY; Lee HJ; Song YW; Lee YJ
    Korean J Intern Med; 2019 Sep; 34(5):1154-1164. PubMed ID: 29458245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
    Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
    Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study.
    Westhoff G; Dörner T; Zink A
    Rheumatology (Oxford); 2012 Feb; 51(2):262-9. PubMed ID: 21705778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sjögren's syndrome in the elderly].
    Gentric-Tilly A
    Ann Med Interne (Paris); 2002 Oct; 153(6):378-82. PubMed ID: 12486386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the diagnosis and treatment of Sjogren's syndrome.
    Chen X; Wu H; Wei W
    Clin Rheumatol; 2018 Jul; 37(7):1743-1749. PubMed ID: 29804149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.
    Nguyen Y; Nocturne G; Henry J; Ng WF; Belkhir R; Desmoulins F; Bergé E; Morel J; Perdriger A; Dernis E; Devauchelle-Pensec V; Sène D; Dieudé P; Couderc M; Fauchais AL; Larroche C; Vittecoq O; Salliot C; Hachulla E; Le Guern V; Gottenberg JE; Mariette X; Seror R
    Lancet Rheumatol; 2024 Apr; 6(4):e216-e225. PubMed ID: 38437852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation and adaptation to Spanish of the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI).
    Posso-Osorio I; Nieto-Aristizábal I; Soto D; Ariza C; Urbano M; Cañas CA; Echeverri A; Castillo A; Tobón GJ
    Reumatol Clin (Engl Ed); 2021; 17(7):388-391. PubMed ID: 34301381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome.
    Seror R; Ravaud P; Bowman SJ; Baron G; Tzioufas A; Theander E; Gottenberg JE; Bootsma H; Mariette X; Vitali C;
    Ann Rheum Dis; 2010 Jun; 69(6):1103-9. PubMed ID: 19561361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sjögren's syndrome: where do we stand, and where shall we go?
    Cornec D; Jamin C; Pers JO
    J Autoimmun; 2014 Jun; 51():109-14. PubMed ID: 24612946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.